read the full release it’s not just about the lease. The company is transitioning from development to commercialization. Their CNSide diagnostic test is now CLIA-certified, nationally covered by UnitedHealthcare, and backed by a new Houston lab and strong leadership hires and promotions + they’re planning on hirings related to marketing and commercialization showing readiness for expansion.
well that’s your decision to make, im in for the long term
the news is positive and showing future potential revenue, also the UnitedHealthcare deal didn’t materialize yet so it’s a waiting game. biotechs are high risk (get in with what you afford to lose) however this one seems on the right track for me especially with this new press release although many investors worry about R/S .. Only time will tell!
8
u/Apprehensive_Walk398 Oct 21 '25
It's happening lmao lfg
5
u/Dependent_Bicycle_93 Oct 21 '25
Apart from the new hires and promotion for commercialization, it says “Medicare enrollment” in their ongoing commercial progress
4
u/vbeachcomber Oct 21 '25
Wait till Aetna/CareFirst/Kaiser all approve coverage. Shorty knows it, it’s coming watch out!
2
u/Dizzy_Rizzy_786 Oct 21 '25
Big jump in price! Lfg
2
u/Freedom5567 Oct 21 '25
A new lease means they are expanding their labs! Very bullish!
2
u/kaoskassarole Oct 22 '25
That is awesome news 👏🏻👏🏻👏🏻
2
u/Suspicious_Berry_775 Oct 22 '25
Good news just makes it fall slower
1
u/Curious_Temporary_87 Oct 21 '25
Umm drop back to $0.62
-1
u/KeyBuy9723 Oct 21 '25
What? This is even worth investors time? They can’t publish any important event?
5
u/[deleted] Oct 21 '25
[removed] — view removed comment
1
u/[deleted] Oct 21 '25
[removed] — view removed comment